Zinc-α-2-Glycoprotein: A Candidate Biomarker for Colon Cancer Diagnosis in Chinese Population
Zinc-α-2-glycoprotein (AZGP1) is a 41-kDa secreted glycoprotein, which has been detected in several malignancies. The diagnostic value of AZGP1 in serum of prostate and breast cancer patients has been reported. Analyzing “The Cancer Genome Atlas” data, we found that in colon cancer AZGP1 gene expres...
Main Authors: | Yingming Xue, Fudong Yu, Dongwang Yan, Feifei Cui, Huamei Tang, Xiaoliang Wang, Jian Chen, Huijun Lu, Senlin Zhao, Zhihai Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/1/691 |
Similar Items
-
Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
by: Huang Yan, et al.
Published: (2012-05-01) -
Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
by: Tang H, et al.
Published: (2016-12-01) -
AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy
by: Mads Dochedahl Winther, et al.
Published: (2020-07-01) -
AZGP1 inhibits soft tissue sarcoma cells invasion and migration
by: Jiayong Liu, et al.
Published: (2018-01-01) -
Changes in AZGP1 Serum Levels and Correlation With Pulse Wave Velocity After Kidney Transplantation
by: Thomas Daniel Kraemer, et al.
Published: (2021-07-01)